Taking Ozempic or Wegovy? New eye warning raises questions in UAE
Dubai: A new US warning about a rare eye condition associated with popular diabetes and weight-loss medicines has raised fresh questions for UAE patients, as recent local research highlights gaps in medicine counselling and the need for more evidence on long-term safety. The US Food and Drug Administration (FDA) has ordered updated safety warnings for GLP-1 medicines, including Novo Nordisk's…
We haven't written up this one. Gulf News has the full story — the link below goes straight to it.
